Escherichia coli E2 is an aerobe human pathogen that has multiple antibiotic resistances and was isolated from bloodculture, human bacteraemia.
antibiotic resistance aerobe human pathogen genome sequence Bacteria| @ref 20215 |
|
|
| Domain Bacteria |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Enterobacterales |
| Family Enterobacteriaceae |
| Genus Escherichia |
| Species Escherichia coli |
| Full scientific name Escherichia coli (Migula 1895) Castellani and Chalmers 1919 (Approved Lists 1980) |
| Synonyms (1) |
| @ref | Gram stain | Confidence | |
|---|---|---|---|
| 125438 | negative | 99.75 |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 24520 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 24520 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | Medium recipe at MediaDive | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water |
| 63750 | Oxygen toleranceaerobe |
| Test 1 | Test 2 | Test 3 | |
|---|---|---|---|
| @ref | 24520 | 24520 | 24520 |
| Medium | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar |
| Manual annotation | 1 | 1 | 1 |
| Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | |
| Amikacin 30µg (disc) | 26 | 24 | 24 |
| Ampicillin 10µg (disc) | 0 | 0 | 0 |
| Aztreonam 30µg (disc) | 36 | 36 | 34 |
| Bacitracin 10Unit | 0 | 0 | 0 |
| Cefalotin 30µg (disc) | 14-16 | 14 | 14 |
| Cefazolin 30µg (disc) | 22 | 22 | 22 |
| Cefotaxime 30µg (disc) | 32 | 32-34 | 32 |
| Ceftriaxone 30µg (disc) | 32 | 32 | 30-32 |
| Chloramphenicol 30µg (disc) | 0 | 0 | 0 |
| Clindamycin 10µg (disc) | 0 | 0 | 0 |
| Colistin 10µg (disc) | 12-14 | 10-12 | 12 |
| Doxycycline 30µg (disc) | 10-12 | 10 | 10-12 |
| Erythromycin 15µg (disc) | 0 | 0 | 8-10 |
| Fosfomycin 50µg (disc) | 36 | 36 | 34 |
| Gentamicin 10µg (disc) | 24 | 24 | 22 |
| Imipenem 10µg (disc) | 32-34 | 34-36 | 32 |
| Kanamycin 30µg (disc) | 22 | 22 | 24 |
| Lincomycin 15µg (disc) | 0 | 0 | 0 |
| Linezolid 10µg (disc) | 0 | 0 | 0 |
| Mezlocillin 30µg (disc) | 16 | 16 | 16 |
| Moxifloxacin 5µg (disc) | 0 | 0 | 0 |
| Neomycin 30µg (disc) | 20 | 20 | 20 |
| Nitrofurantoin 100µg (disc) | 22 | 22 | 22 |
| Norfloxacin 10µg (disc) | 0 | 0 | 0 |
| Nystatin 100Unit | 0 | 0 | 0 |
| Ofloxacin 5µg (disc) | 0 | 0 | 0 |
| Oxacillin 5µg (disc) | 0 | 0 | 0 |
| Penicillin G 6µg (disc) | 0 | 0 | 0 |
| Pipemidic acid 20µg (disc) | 0 | 0 | 0 |
| Piperacillin/Tazobactam 40µg (disc) | 24 | 24-26 | 24 |
| Polymyxin B 300Unit | 14-16 | 14 | 16 |
| Quinupristin/Dalfopristin 15µg (disc) | 0 | 0 | 0 |
| Teicoplanin 30µg (disc) | 0 | 0 | 0 |
| Tetracycline 30µg (disc) | 0 | 0 | 0 |
| Ticarcillin 75µg (disc) | 0 | 0 | 0 |
| Vancomycin 30µg (disc) | 0 | 0 | 6 |
| @ref | Spore formation | Confidence | |
|---|---|---|---|
| 125439 | 94.091 |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68368 | 27613 ChEBI | amygdalin | - | fermentation | from API 20E |
| 68374 | 29016 ChEBI | arginine | - | hydrolysis | from API ID32E |
| 68368 | 29016 ChEBI | arginine | - | hydrolysis | from API 20E |
| 68374 | 17057 ChEBI | cellobiose | - | builds acid from | from API ID32E |
| 68374 | 18333 ChEBI | D-arabitol | - | builds acid from | from API ID32E |
| 68374 | 18024 ChEBI | D-galacturonic acid | + | builds acid from | from API ID32E |
| 68374 | 17634 ChEBI | D-glucose | + | builds acid from | from API ID32E |
| 68368 | 17634 ChEBI | D-glucose | + | fermentation | from API 20E |
| 68374 | 16899 ChEBI | D-mannitol | + | builds acid from | from API ID32E |
| 68368 | 16899 ChEBI | D-mannitol | + | fermentation | from API 20E |
| 68368 | 5291 ChEBI | gelatin | - | hydrolysis | from API 20E |
| 68374 | 30849 ChEBI | L-arabinose | + | builds acid from | from API ID32E |
| 68374 | 18403 ChEBI | L-arabitol | - | builds acid from | from API ID32E |
| 68374 | 62345 ChEBI | L-rhamnose | + | builds acid from | from API ID32E |
| 68368 | 62345 ChEBI | L-rhamnose | + | fermentation | from API 20E |
| 68374 | 25094 ChEBI | lysine | + | degradation | from API ID32E |
| 68368 | 25094 ChEBI | lysine | + | degradation | from API 20E |
| 68374 | 15792 ChEBI | malonate | - | assimilation | from API ID32E |
| 68374 | 17306 ChEBI | maltose | + | builds acid from | from API ID32E |
| 68368 | 28053 ChEBI | melibiose | + | fermentation | from API 20E |
| 68374 | 17268 ChEBI | myo-inositol | - | builds acid from | from API ID32E |
| 68368 | 17268 ChEBI | myo-inositol | - | fermentation | from API 20E |
| 68374 | 18257 ChEBI | ornithine | - | degradation | from API ID32E |
| 68368 | 18257 ChEBI | ornithine | - | degradation | from API 20E |
| 68374 | 18394 ChEBI | palatinose | - | builds acid from | from API ID32E |
| 68374 | 0 ChEBI | Potassium 5-ketogluconate | - | builds acid from | from API ID32E |
| 68374 | 15963 ChEBI | ribitol | - | builds acid from | from API ID32E |
| 68374 | 30911 ChEBI | sorbitol | - | builds acid from | from API ID32E |
| 68368 | 30911 ChEBI | sorbitol | + | fermentation | from API 20E |
| 68374 | 17992 ChEBI | sucrose | + | builds acid from | from API ID32E |
| 68368 | 17992 ChEBI | sucrose | + | fermentation | from API 20E |
| 68374 | 27082 ChEBI | trehalose | + | builds acid from | from API ID32E |
| 68374 | 27897 ChEBI | tryptophan | + | energy source | from API ID32E |
| 68374 | 16199 ChEBI | urea | - | hydrolysis | from API ID32E |
| 68368 | 16199 ChEBI | urea | - | hydrolysis | from API 20E |
| @ref | ChEBI | Metabolite | Is resistant | Resistance conc. | |
|---|---|---|---|---|---|
| 24520 | 28971 | Ampicillin | 10 µg (disc) | from Antibiotic test | |
| 24520 | 28669 | Bacitracin | 10 Unit | from Antibiotic test | |
| 24520 | 17698 | Chloramphenicol | 30 µg (disc) | from Antibiotic test | |
| 24520 | 3745 | Clindamycin | 10 µg (disc) | from Antibiotic test | |
| 24520 | 6472 | Lincomycin | 15 µg (disc) | from Antibiotic test | |
| 24520 | 63607 | Linezolid | 10 µg (disc) | from Antibiotic test | |
| 24520 | 63611 | Moxifloxacin | 5 µg (disc) | from Antibiotic test | |
| 24520 | 100246 | Norfloxacin | 10 µg (disc) | from Antibiotic test | |
| 24520 | 7660 | Nystatin | 100 Unit | from Antibiotic test | |
| 24520 | 7731 | Ofloxacin | 5 µg (disc) | from Antibiotic test | |
| 24520 | 7809 | Oxacillin | 5 µg (disc) | from Antibiotic test | |
| 24520 | 18208 | Penicillin G | 6 µg (disc) | from Antibiotic test | |
| 24520 | 75250 | Pipemidic acid | 20 µg (disc) | from Antibiotic test | |
| 24520 | Quinupristin/Dalfopristin | 15 µg (disc) | from Antibiotic test | ||
| 24520 | 29687 | Teicoplanin | 30 µg (disc) | from Antibiotic test | |
| 24520 | 27902 | Tetracycline | 30 µg (disc) | from Antibiotic test | |
| 24520 | 9587 | Ticarcillin | 75 µg (disc) | from Antibiotic test |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68374 | alpha-galactosidase | + | 3.2.1.22 | from API ID32E |
| 68374 | alpha-glucosidase | - | 3.2.1.20 | from API ID32E |
| 68374 | alpha-maltosidase | - | from API ID32E | |
| 68374 | arginine dihydrolase | - | 3.5.3.6 | from API ID32E |
| 68368 | arginine dihydrolase | - | 3.5.3.6 | from API 20E |
| 68374 | beta-galactosidase | + | 3.2.1.23 | from API ID32E |
| 68368 | beta-galactosidase | + | 3.2.1.23 | from API 20E |
| 68374 | beta-glucosidase | - | 3.2.1.21 | from API ID32E |
| 68374 | beta-glucuronidase | + | 3.2.1.31 | from API ID32E |
| 68368 | gelatinase | - | from API 20E | |
| 68374 | L-aspartate arylamidase | - | 3.4.11.21 | from API ID32E |
| 68374 | lipase | - | from API ID32E | |
| 68374 | lysine decarboxylase | + | 4.1.1.18 | from API ID32E |
| 68368 | lysine decarboxylase | + | 4.1.1.18 | from API 20E |
| 68374 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API ID32E |
| 68374 | ornithine decarboxylase | - | 4.1.1.17 | from API ID32E |
| 68368 | ornithine decarboxylase | - | 4.1.1.17 | from API 20E |
| 68368 | tryptophan deaminase | - | 4.1.99.1 | from API 20E |
| 68374 | urease | - | 3.5.1.5 | from API ID32E |
| 68368 | urease | - | 3.5.1.5 | from API 20E |
| @ref | ONPG | ADH (Arg) | LDC (Lys) | ODC | CIT | H2S productionH2S | URE | TDA (Trp) | IND | Acetoin production (Voges Proskauer test)VP | GEL | GLU | MAN | INO | Sor | RHA | SAC | MEL | AMY | ARA | OX | Nitrite productionNO2 | Reduction to N2N2 | MotilityMOB | Growth on MacConkey mediumMAC | OF-O | OF-F | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24520 | + | - | + | - | + | - | - | - | - | +/- | - | + | + | - | + | + | + | + | - | + | - | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | |
| 24520 | + | - | + | - | - | - | - | - | + | - | - | + | + | - | + | + | + | + | - | - | + | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | |
| 24520 | + | - | + | - | - | - | - | - | + | + | - | + | + | - | + | + | + | + | - | + | - | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | |
| 63750 | + | - | + | - | - | - | - | - | + | - | - | + | + | - | + | + | + | + | - | + | - | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. |
| @ref | ODC | ADH (Arg) | LDC (Lys) | URE | LARL | GAT | 5KG | LipaseLIP | Phenol red (Acidification)RP | beta GLU | MAN | MAL | ADO | PLE | beta GUR | MNT | IND | N-Acetyl-beta-Glucosaminidasebeta NAG | beta GAL | GLU | SAC | LARA | DARL | alpha GLU | alpha GAL | TRE | RHA | INO | CEL | SOR | alpha-MaltosidasealphaMAL | L-aspartic acid arylamidaseAspA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63750 | - | - | + | - | - | + | - | - | + | - | + | + | - | - | + | - | + | - | + | + | + | + | - | - | + | + | + | - | - | - | - | - |
| @ref | Pathogenicity human | Pathogenicity animal | Biosafety level | Biosafety level comment | |
|---|---|---|---|---|---|
| 24520 | 2 | Risk group (German classification) |
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 66792 | ASM2088351v1 assembly for Escherichia coli E2 | complete | 562 | 99.04 | ||||
| 66792 | ASM1888406v1 assembly for Escherichia coli E2 | complete | 562 | 98.37 | ||||
| 66792 | ASM2536967v1 assembly for Escherichia coli E2 | complete | 562 | 97.97 | ||||
| 66792 | 50624_F01 assembly for Escherichia coli NCTC13846 | contig | 562 | 76.81 | ||||
| 66792 | ASM332809v1 assembly for Escherichia coli E2 | contig | 562 | 63.25 | ||||
| 66792 | ASM150965v1 assembly for Escherichia coli E2 | scaffold | 562 | 33.78 | ||||
| 66792 | E2 assembly for Escherichia coli | contig | 562 | 32.22 | ||||
| 66792 | ASM1716247v1 assembly for Escherichia coli E2 | contig | 562 | 32.12 | ||||
| 66792 | ASM169355v1 assembly for Escherichia coli E2 | scaffold | 562 | 19.17 | ||||
| 66792 | ASM2055658v1 assembly for Escherichia coli E2 | contig | 562 | 13.79 | ||||
| 66792 | ASM227713v1 assembly for Escherichia coli E2 | scaffold | 562 | 12.01 | ||||
| 66792 | 15.TR.002_2OXA_OXA-48 assembly for Escherichia coli | scaffold | 562 | 0 |
| @ref | Trait | Model | Prediction | Confidence in % | In training data |
|---|---|---|---|---|---|
| 125439 | gram_stain | BacteriaNetⓘ | negative | 75.11 | no |
| 125439 | oxygen_tolerance | BacteriaNetⓘ | obligate aerobe | 88.68 | no |
| 125439 | motility | BacteriaNetⓘ | yes | 53.05 | no |
| 125439 | spore_formation | BacteriaNetⓘ | no | 94.09 | no |
| @ref | Trait | Model | Prediction | Confidence in % | In training data |
|---|---|---|---|---|---|
| 125438 | gram-positive | gram-positiveⓘ | no | 99.75 | no |
| 125438 | anaerobic | anaerobicⓘ | no | 96.02 | yes |
| 125438 | aerobic | aerobicⓘ | no | 57.98 | yes |
| 125438 | spore-forming | spore-formingⓘ | no | 85.95 | no |
| 125438 | thermophilic | thermophileⓘ | no | 98.50 | yes |
| 125438 | flagellated | motile2+ⓘ | yes | 78.94 | no |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| In Vitro Screening of a 1280 FDA-Approved Drugs Library against Multidrug-Resistant and Extensively Drug-Resistant Bacteria. | Peyclit L, Baron SA, Hadjadj L, Rolain JM. | Antibiotics (Basel) | 10.3390/antibiotics11030291 | 2022 | ||
| The Rare Actinobacterium Crossiella sp. Is a Potential Source of New Bioactive Compounds with Activity against Bacteria and Fungi. | Gonzalez-Pimentel JL, Dominguez-Monino I, Jurado V, Laiz L, Caldeira AT, Saiz-Jimenez C. | Microorganisms | 10.3390/microorganisms10081575 | 2022 | ||
| Evaluation of Colistin Susceptibility in Carbapenem-Resistant Acinetobacter baumannii Isolates Using Broth Microdilution, MICRONAUT-MIC-Strip, and VITEK MS. | Akilli FM, Ilki A. | Microbiologyopen | 10.1002/mbo3.70046 | 2025 | ||
| Evaluation of an automated antimicrobial susceptibility testing system performance for colistin susceptibility in carbapenem-resistant Acinetobacter baumannii isolates. | Ilki A, Akilli FM, Ozsoy SA, Saygi Z, Yuceel-Timur I. | Microbiol Spectr | 10.1128/spectrum.00859-25 | 2025 | ||
| Lipopolysaccharide clustering in colistin persistent and resistant bacteria. | Wang F, Merces G, Alderson D, Wollman AJM, Geoghegan M, Chang CY. | NPJ Antimicrob Resist | 10.1038/s44259-025-00158-4 | 2025 | ||
| Study on the Mobile Colistin Resistance (mcr-1) Gene in Gram-Negative Bacilli in a Rural Tertiary Care Hospital in Western Maharashtra. | Yadav KS, Pawar S, Datkhile K, Patil SR. | Cureus | 10.7759/cureus.75569 | 2024 | ||
| Ceftazidime and Usnic Acid Encapsulated in Chitosan-Coated Liposomes for Oral Administration against Colorectal Cancer-Inducing Escherichia coli. | de Souza JB, de Lacerda Coriolano D, Dos Santos Silva RC, da Costa Junior SD, de Almeida Campos LA, Cavalcanti IDL, Lira Nogueira MCB, Pereira VRA, Brelaz-de-Castro MCA, Cavalcanti IMF. | Pharmaceuticals (Basel) | 10.3390/ph17060802 | 2024 | ||
| The conjugative transfer of plasmid-mediated mobile colistin resistance gene, mcr-1, to Escherichia coli O157:H7 and Escherichia coli O104:H4 in nutrient broth and in mung bean sprouts. | Luo X, Matthews KR. | Food Microbiology. | 2023 | |||
| Ceftazidime and Usnic Acid Encapsulated in Chitosan-Coated Liposomes for Oral Administration against Colorectal Cancer-Inducing Escherichia coli | de Souza J, de Lacerda Coriolano D, dos Santos Silva R, da Costa Junior S, de Almeida Campos L, Cavalcanti I, Lira Nogueira M, Pereira V, Brelaz-de-Castro M, Cavalcanti I. | Pharmaceuticals (Basel) | 2024 | |||
| Genetics | Whole-Genome Sequencing of Klebsiella quasipneumoniae subsp. similipneumoniae Isolated from a Patient with Pneumonia. | Sekowska A, Konechnyi Y, Carrazco-Montalvo A. | Curr Microbiol | 10.1007/s00284-025-04414-8 | 2025 | |
| Determination of Colistin Resistance in Clinical Isolates from Healthcare Facilities in Mthatha and Surrounding Areas. | Ndlela S, Singh R, Vasaikar S. | Antibiotics (Basel) | 10.3390/antibiotics14050505 | 2025 | ||
| An Effective Modification Strategy to Build Multifunctional Peptides Based on a Trypsin Inhibitory Peptide of the Kunitz Family. | Wang Y, Shi D, Zou W, Jiang Y, Wang T, Chen X, Ma C, Li W, Chen T, Burrows JF, Wang L, Zhou M. | Pharmaceutics | 10.3390/pharmaceutics16050597 | 2024 | ||
| The Use of CHROMID® Colistin R for the Detection of Colistin-Resistant Gram-Negative Bacteria in Positive Blood Cultures. | Marrs ECL, Milburn O, Eltringham GJ, Fenwick DJC, Orenga S, Hazirolan G, Zarakolu P, Perry JD. | Antibiotics (Basel) | 10.3390/antibiotics13030246 | 2024 | ||
| Salmonella serovars in a tertiary hospital in Turkey, 2015-2017: molecular epidemiology, antimicrobial resistance and molecular characteristics of resistance mechanisms. | Unalan-Altintop T, Demirci-Duarte S, Koseoglu-Eser O, Gundogdu A, Cakar A, Gulesen R, Levent B, Altun B, Sancak B, Gur D. | Afr Health Sci | 10.4314/ahs.v25i2.10 | 2025 | ||
| Detection and Characterisation of Colistin-Resistant Escherichia coli in Broiler Meats. | Tanzin AZ, Nath C, Nayem MRK, Sayeed MA, Khan SA, Magalhaes RS, Alawneh JI, Hassan MM. | Microorganisms | 10.3390/microorganisms12122535 | 2024 | ||
| Antimicrobial resistance prevalence in Escherichia coli from German fattening pigs differs at subnational levels. | Richter M, Weber M, Homeier-Bachmann T, Leitner C, Amler S, Heydel C, Ewers C, Berens C, Menge C. | Appl Environ Microbiol | 10.1128/aem.00878-25 | 2025 | ||
| Investigation of Plasmid-Mediated Colistin Resistance Genes (mcr-1-8) in Enterobacterales Isolates. | Gurbuz M, Turkekul Sen E, Simsek M, Demir C. | Cureus | 10.7759/cureus.61538 | 2024 | ||
| Colistin Insusceptibility in Carbapenem-Resistant Enterobacteriaceae Isolates From a Tertiary Referral Centre. | Hait PS, Pawar SK, Patil SR. | Cureus | 10.7759/cureus.71329 | 2024 | ||
| Flow Cytometry as a Rapid and Valuable Method in Investigation of Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae Isolates. | Ucak SC, Ongen B. | Antibiotics (Basel) | 10.3390/antibiotics13050418 | 2024 | ||
| First report of mobile colistin resistance gene mcr-1 in avian pathogenic Escherichia coli isolated from turkeys in the Gaza Strip, Palestine. | Thabet AM, Alzuheir IM, Laham NAA, Helal BYA, Fayyad AF, Jalboush NH, Gharaibeh MH. | Vet World | 10.14202/vetworld.2023.1260-1265 | 2023 | ||
| Optimized methods for the targeted surveillance of extended-spectrum beta-lactamase-producing Escherichia coli in human stool. | Gallichan S, Forrest S, Picton-Barlow E, McKeown C, Moore M, Heinz E, Feasey NA, Lewis JM, Graf FE. | Microbiol Spectr | 10.1128/spectrum.01058-24 | 2025 | ||
| Antimicrobial Peptidomimetics Prevent the Development of Resistance against Gentamicin and Ciprofloxacin in Staphylococcus and Pseudomonas Bacteria. | Browne K, Kuppusamy R, Walsh WR, Black DS, Willcox MDP, Kumar N, Chen R. | Int J Mol Sci | 10.3390/ijms241914966 | 2023 | ||
| Serendipitous Hinge Modulation Hypothetically Reprograms Caerin 1.1-LC Antibacterial Mechanism and Gram-Negative Selectivity. | Sun Z, Zhao R, Zhang Y, Ma X, Jiang Y, Wang T, Chen X, Ma C, Chen T, Shaw C, Zhou M, Wang L. | Pharmaceutics | 10.3390/pharmaceutics17111500 | 2025 | ||
| An Evaluation of the ASTar Automated Antimicrobial Testing System for Gram-Negative Bacteria in Positive Blood Cultures. | Coulson H, Ivin A, Day KM, Fenwick DJC, Marrs ECL, Mpwilu P, Perry JD. | Antibiotics (Basel) | 10.3390/antibiotics14030249 | 2025 | ||
| Silver Nanoparticles Functionalized with Polymeric Substances to Reduce the Growth of Planktonic and Biofilm Opportunistic Pathogens. | Solomon M, Holban AM, Balaceanu-Gurau B, Ditu LM, Alberts A, Grumezescu AM, Manolescu LSC, Mihai MM. | Int J Mol Sci | 10.3390/ijms26093930 | 2025 | ||
| Rapid culture-independent loop-mediated isothermal amplification detection of antimicrobial resistance markers from environmental water samples. | Hassan MM, van Vliet AHM, Higgins O, Burke LP, Chueiri A, O'Connor L, Morris D, Smith TJ, La Ragione RM. | Microb Biotechnol | 10.1111/1751-7915.14227 | 2023 | ||
| Genetics | The First Report of mcr-1-Carrying Escherichia coli, Isolated from a Clinical Sample in the North-East of Romania. | Vlad MA, Lixandru BE, Muntean AA, Trandafir I, Lunca C, Tuchilus C. | Microorganisms | 10.3390/microorganisms12122461 | 2024 | |
| Comparative Analysis of Colistin Resistance in Pseudomonas aeruginosa: VITEK® 2 Compact Versus Broth Microdilution Method. | Yadav KS, Pawar S, Yadav SA, Patil S. | Cureus | 10.7759/cureus.76646 | 2024 | ||
| Thymus algeriensis essential oil: Phytochemical investigation, bactericidal activity, synergistic effect with colistin, molecular docking, and dynamics analysis against Gram-negative bacteria resistant to colistin. | Ben Selma W, Farouk A, Ban Z, Ferjeni M, Alsulami T, Ali H, Boukadida J. | Heliyon | 10.1016/j.heliyon.2024.e38281 | 2024 | ||
| Comparative Evaluation of Colistin Broth Disk Elution Method With Two Commercially Available Systems for Colistin Susceptibility Testing Against Carbapenem-Resistant Klebsiella pneumoniae: A Single-Center Exploratory Study. | Singh A, Bhatia M, Rekha S, Rani D, Kamboj P, Chakraborty D, Gupta P. | Cureus | 10.7759/cureus.25549 | 2022 | ||
| Resisting the Final Line: Phenotypic Detection of Resistance to Last-Resort Antimicrobials in Gram-Negative Bacteria Isolated from Wild Birds in Northern Italy | Rapi M, Filipe J, Filippone Pavesi L, Raimondi S, Addis M, Franciosini M, Grilli G. | Animals (Basel) | 2025 | |||
| Characterization of genome-wide transpositions induced by colistin exposure in multi-drug-resistant Klebsiella pneumoniae. | Rajakani SG, Xavier BB, Nguyen NM, Lin Q, Braspenning A, Plantinga NL, Wittekamp BHJ, Zarkotou O, Van Houdt R, Glupczynski Y, Pournaras S, Bonten MJM, Malhotra-Kumar S. | Antimicrob Agents Chemother | 10.1128/aac.01574-24 | 2025 | ||
| Comparative Evaluation of Two Automated ID/AST Systems and Mikrolatest Kit in Assessing the In Vitro Colistin Susceptibility of Carbapenem-Resistant Enterobacteriaceae Isolates: A Single-Center Exploratory Study from North India. | Bhatia M, Singh RI, Rani D, Rekha US, Rohilla R, Omar BJ, Gupta P. | J Pharm Bioallied Sci | 10.4103/jpbs.jpbs_651_21 | 2022 | ||
| Discovery, development and optimisation of a novel frog antimicrobial peptide with combined mode of action against drug-resistant bacteria. | Wang J, Hu J, Pu W, Chen X, Ma C, Jiang Y, Wang T, Chen T, Shaw C, Zhou M, Wang L. | Comput Struct Biotechnol J | 10.1016/j.csbj.2024.09.006 | 2024 | ||
| Cinnamic Acid Compounds (p-Coumaric, Ferulic, and p-Methoxycinnamic Acid) as Effective Antibacterial Agents Against Colistin-Resistant Acinetobacter baumannii. | Korkut A, Ozkaya Gul S, Aydemir E, Er H, Odabas Kose E. | Antibiotics (Basel) | 10.3390/antibiotics14010071 | 2025 | ||
| Genetics | Analysis of colistin resistance in carbapenem-resistant Enterobacterales and XDR Klebsiella pneumoniae. | Bir R, Gautam H, Arif N, Chakravarti P, Verma J, Banerjee S, Tyagi S, Mohapatra S, Sood S, Dhawan B, Chaudhry R, Kapil A, Das BK, Das B. | Ther Adv Infect Dis | 10.1177/20499361221080650 | 2022 | |
| Risk Factors and Outcomes for Isolation with Polymyxin B-Resistant Enterobacterales from 2018-2022: A Case-Control Study. | Yan W, Wu J, Wang S, Zhang Q, Yuan Y, Jing N, Zhang J, He H, Li Y. | Infect Drug Resist | 10.2147/idr.s435697 | 2023 | ||
| 'Breakpoint broth microdilution plate' for susceptibility testing of Gram negative bacilli against colistin sulfate. | Ahmed I, Laiq S, Shaheen N, Wahab K, Farooqi J, Shahid A, Hasan R, Shakoor S. | Pract Lab Med | 10.1016/j.plabm.2020.e00192 | 2020 | ||
| Outbreak of High-Risk Clone ST323 Klebsiella pneumoniae Resistant to Ceftazidime-Avibactam Due to Acquisition of blaVEB-25 and to Cefiderocol Due to Mutated fiu Gene. | Galani I, Karaiskos I, Souli M, Papoutsaki V, Gkoufa A, Antoniadou A, Giamarellou H. | Antibiotics (Basel) | 10.3390/antibiotics14030223 | 2025 | ||
| Alkyl deoxyglycoside-polymyxin combinations against critical priority carbapenem-resistant gram-negative bacteria. | de Matos AM, Calado P, Miranda M, Almeida R, Rauter AP, Oliveira MC, Manageiro V, Canica M. | Sci Rep | 10.1038/s41598-024-51428-6 | 2024 | ||
| Effective Immobilization of Novel Antimicrobial Peptides via Conjugation onto Activated Silicon Catheter Surfaces. | Soyhan I, Polat T, Mozioglu E, Ozal Ildeniz TA, Acikel Elmas M, Cebeci S, Unubol N, Gok O. | Pharmaceutics | 10.3390/pharmaceutics16081045 | 2024 | ||
| Genetics | Characterizing arginine, ornithine, and putrescine pathways in enteric pathobionts. | Lillie IM, Booth CE, Horvath AE, Mondragon M, Engevik MA, Horvath TD. | Microbiologyopen | 10.1002/mbo3.1408 | 2024 | |
| Detection of Colistin Resistance in Carbapenem Resistant Enterobacteriaceae by Reference Broth Microdilution and Comparative Evaluation of Three Other Methods. | Kar P, Behera B, Mohanty S, Jena J, Mahapatra A. | J Lab Physicians | 10.1055/s-0041-1731137 | 2021 | ||
| [Evaluation of the Two Commercial Methods Based on Broth Microdilution Against Reference Microdilution Method for Klebsiella pneumoniae Isolates]. | Kansak N, Aslan M, Adaleti R, Aksaray S. | Mikrobiyol Bul | 10.5578/mb.69828 | 2020 | ||
| Performance evaluation of colistin rapid NP test for detection of colistin resistance in colistin resistant Enterobacterales. | Kar P, Behera B, Mohanty S, Jena J, Mahapatra A. | Med J Armed Forces India | 10.1016/j.mjafi.2022.04.006 | 2024 | ||
| Pathogenicity | Outer Membrane Interaction Kinetics of New Polymyxin B Analogs in Gram-Negative Bacilli. | Akhoundsadegh N, Belanger CR, Hancock REW. | Antimicrob Agents Chemother | 10.1128/aac.00935-19 | 2019 | |
| ESKAPE pathogens rapidly develop resistance against antibiotics in development in vitro. | Daruka L, Czikkely MS, Szili P, Farkas Z, Balogh D, Grezal G, Maharramov E, Vu TH, Sipos L, Juhasz S, Dunai A, Daraba A, Szamel M, Sari T, Stirling T, Vasarhelyi BM, Ari E, Christodoulou C, Manczinger M, Enyedi MZ, Jaksa G, Kovacs K, van Houte S, Pursey E, Pinter L, Haracska L, Kintses B, Papp B, Pal C. | Nat Microbiol | 10.1038/s41564-024-01891-8 | 2025 | ||
| The occurrence and molecular detection of mcr-1 and mcr-5 genes in Enterobacteriaceae isolated from poultry and poultry meats in Malaysia. | Karim MR, Zakaria Z, Hassan L, Faiz NM, Ahmad NI. | Front Microbiol | 10.3389/fmicb.2023.1208314 | 2023 | ||
| Clinical and microbiological evaluation of ventilator-associated pneumonia in an intensive care unit in Vietnam. | Hayakawa K, Binh NG, Co DX, Thach PT, Phuong Thuy PT, Chau NQ, Huong ML, Van Thanh D, Phuong DM, Miyoshi-Akiyama T, Nagashima M, Ohmagari N. | Infect Prev Pract | 10.1016/j.infpip.2023.100318 | 2023 | ||
| Evaluation of Commercial Products for Colistin and Polymyxin B Susceptibility Testing for mcr-Positive and Negative Escherichia coli and Klebsiella pneumoniae in China. | Zhang Q, Yan W, Zhu Y, Jing N, Wang S, Yuan Y, Ma B, Xu J, Chu Y, Zhang J, Ma Q, Wang B, Xu W, Zhu L, Sun Y, Shi C, Fang J, Li Y, Liu S. | Infect Drug Resist | 10.2147/idr.s400772 | 2023 | ||
| Low performance of Policimbac® broth microdilution in determining polymyxin B MIC for Klebsiella pneumoniae. | Rocha NC, Lopes JM, Russi KL, Palmeiro JK, Girardello R. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1139784 | 2023 | ||
| Insight into Antibiotic Synergy Combinations for Eliminating Colistin Heteroresistant Klebsiella pneumoniae. | Rajakani SG, Xavier BB, Sey A, Mariem EB, Lammens C, Goossens H, Glupczynski Y, Malhotra-Kumar S. | Genes (Basel) | 10.3390/genes14071426 | 2023 | ||
| Genomic epidemiology and resistome dynamics of Enterobacter species in a Portuguese Open Air Laboratory: the emergence of the FRI-8 carbapenemase. | Teixeira P, Ramos M, Riviere R, Azevedo M, Ferreira M, Cano MM, Vieira P, Reis L, Matias R, Rodrigues J, Menezes C, Rosado T, Sequeira A, Moreira O, Ruppitsch W, Cabal-Rosel A, Mo SS, Dias E, Woegerbauer M, Canica M, Manageiro V. | Front Microbiol | 10.3389/fmicb.2025.1593872 | 2025 | ||
| Pathogenicity | Evaluation of rapid colistin susceptibility directly from positive blood cultures using a flow cytometry assay. | Fonseca E Silva D, Silva-Dias A, Gomes R, Martins-Oliveira I, Ramos MH, Rodrigues AG, Canton R, Pina-Vaz C. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2019.08.016 | 2019 | |
| Double carbapenemases in Klebsiella pneumoniae blood isolates: dissemination in a single medical center via multiple plasmids and a variety of highly efficient clones. | Rigatou A, Afolayan AO, Tatsi E-B, Deliolanis I, Michos A, Reuter S, Daikos GL. | Antimicrob Agents Chemother | 10.1128/aac.01462-24 | 2025 | ||
| Pathogenicity | Effects of Escherichia coli LPS Structure on Antibacterial and Anti-Endotoxin Activities of Host Defense Peptides. | Javed A, Balhuizen MD, Pannekoek A, Bikker FJ, Heesterbeek DAC, Haagsman HP, Broere F, Weingarth M, Veldhuizen EJA. | Pharmaceuticals (Basel) | 10.3390/ph16101485 | 2023 | |
| Carriage of Plasmid-Mediated Colistin Resistance-1-Positive Escherichia coli in Humans, Animals, and Environment on Farms in Vietnam. | Nguyen PTL, Tran HTM, Tran HA, Pham TD, Luong TM, Nguyen TH, Nguyen LTP, Nguyen TTT, Hoang HTA, Nguyen C, Tran DN, Dang AD, Suzuki M, Le TV, Banuls AL, Choisy M, Van Doorn RH, Tran HH. | Am J Trop Med Hyg | 10.4269/ajtmh.21-1203 | 2022 | ||
| Comparison of Six Phenotypic Assays with Reference Methods for Assessing Colistin Resistance in Clinical Isolates of Carbapenemase-Producing Enterobacterales: Challenges and Opportunities. | Foldes A, Szekely E, Voidazan ST, Dobreanu M. | Antibiotics (Basel) | 10.3390/antibiotics11030377 | 2022 | ||
| Hybrid Sequencing-Based Genomic Analysis of Klebsiella pneumoniae from Urinary Tract Infections Among Inpatients at a Tertiary Hospital in Beijing. | Zhang W, Wang Y, Wang K, Li J, Liu J, Li S, Song L, Liao C, Yang X, Li P, Liu X. | Infect Drug Resist | 10.2147/idr.s448253 | 2024 | ||
| Antimicrobial Resistance in Escherichia coli and Its Correlation with Antimicrobial Use on Commercial Poultry Farms in Bangladesh. | Ibrahim N, Boyen F, Mohsin MAS, Ringenier M, Berge AC, Chantziaras I, Fournie G, Pfeiffer D, Dewulf J. | Antibiotics (Basel) | 10.3390/antibiotics12091361 | 2023 | ||
| Repeated Occurrence of Mobile Colistin Resistance Gene-Carrying Plasmids in Pathogenic Escherichia coli from German Pig Farms. | Gopel L, Prenger-Berninghoff E, Wolf SA, Semmler T, Bauerfeind R, Ewers C. | Microorganisms | 10.3390/microorganisms12040729 | 2024 | ||
| The Effect of Colistin Treatment on the Selection of Colistin-Resistant Escherichia coli in Weaner Pigs. | Ahmed S, Hansen C, Dahlkilde AL, Herrero-Fresno A, Pedersen KS, Nielsen JP, Olsen JE. | Antibiotics (Basel) | 10.3390/antibiotics10040465 | 2021 | ||
| In Vitro Activity of "Old" and "New" Antimicrobials against the Klebsiella pneumoniae Complex. | Sekowska A. | Antibiotics (Basel) | 10.3390/antibiotics13020126 | 2024 | ||
| Antimicrobial Resistance Profiles and Co-Existence of Multiple Antimicrobial Resistance Genes in mcr-Harbouring Colistin-Resistant Enterobacteriaceae Isolates Recovered from Poultry and Poultry Meats in Malaysia. | Karim MR, Zakaria Z, Hassan L, Mohd Faiz N, Ahmad NI. | Antibiotics (Basel) | 10.3390/antibiotics12061060 | 2023 | ||
| Synergistic Effect between Usnic Acid and Polymyxin B against Resistant Clinical Isolates of Pseudomonas aeruginosa. | da Costa Junior SD, da Silva WRC, da Silva AMCM, Maciel MAV, Cavalcanti IMF. | Evid Based Complement Alternat Med | 10.1155/2020/9852145 | 2020 | ||
| Pathogenicity | Polymyxin B Etest® compared with gold-standard broth microdilution in carbapenem-resistant Enterobacteriaceae exhibiting a wide range of polymyxin B MICs. | Kulengowski B, Ribes JA, Burgess DS. | Clin Microbiol Infect | 10.1016/j.cmi.2018.04.008 | 2019 | |
| Synthesis and antimicrobial activity of aminoalkyl resveratrol derivatives inspired by cationic peptides. | Cebrian R, Lucas R, Fernandez-Cantos MV, Slot K, Penalver P, Martinez-Garcia M, Parraga-Leo A, de Paz MV, Garcia F, Kuipers OP, Morales JC. | J Enzyme Inhib Med Chem | 10.1080/14756366.2022.2146685 | 2023 | ||
| One Health surveillance of colistin-resistant Enterobacterales in Belgium and the Netherlands between 2017 and 2019. | De Koster S, Xavier BB, Lammens C, Perales Selva N, van Kleef-van Koeveringe S, Coenen S, Glupczynski Y, Leroux-Roels I, Dhaeze W, Hoebe CJPA, Dewulf J, Stegeman A, Kluytmans-Van den Bergh M, Kluytmans J, Goossens H, i-4-1-Health Study Group. | PLoS One | 10.1371/journal.pone.0298096 | 2024 | ||
| Characterisation of colistin resistance in Gram-negative microbiota of pregnant women and neonates in Nigeria. | Portal EAR, Sands K, Farley C, Boostrom I, Jones E, Barrell M, Carvalho MJ, Milton R, Iregbu K, Modibbo F, Uwaezuoke S, Akpulu C, Audu L, Edwin C, Yusuf AH, Adeleye A, Mukkadas AS, Maduekwe D, Gambo S, Sani J, Walsh TR, Spiller OB. | Nat Commun | 10.1038/s41467-024-45673-6 | 2024 | ||
| Genetics | First Description of Mergibacter septicus Isolated from a Common Tern (Sterna hirundo) in Germany. | Abdel-Glil MY, Braune S, Bouwhuis S, Sprague LD. | Pathogens | 10.3390/pathogens12091096 | 2023 | |
| Pathogenicity | Comparative evaluation of the UMIC Colistine kit to assess MIC of colistin of gram-negative rods. | Bardet L, Okdah L, Le Page S, Baron SA, Rolain JM. | BMC Microbiol | 10.1186/s12866-019-1424-8 | 2019 | |
| Effects of deferoxamine on intrinsic colistin resistance of Proteus mirabilis. | Erinmez M, Zer Y. | Exp Ther Med | 10.3892/etm.2023.12158 | 2023 | ||
| Pathogenicity | Colistin resistance in Gram-negative bacteria analysed by five phenotypic assays and inference of the underlying genomic mechanisms. | Torres DA, Seth-Smith HMB, Joosse N, Lang C, Dubuis O, Nuesch-Inderbinen M, Hinic V, Egli A. | BMC Microbiol | 10.1186/s12866-021-02388-8 | 2021 | |
| Quercetin: Synergistic Interaction with Antibiotics against Colistin-Resistant Acinetobacter baumannii. | Odabas Kose E, Koyuncu Ozyurt O, Bilmen S, Er H, Kilit C, Aydemir E. | Antibiotics (Basel) | 10.3390/antibiotics12040739 | 2023 | ||
| Evaluation of different methods for in vitro susceptibility testing of colistin in carbapenem resistant Gram-negative bacilli. | Rout B, Dash SK, Sahu KK, Behera B, Praharaj I, Otta S. | Access Microbiol | 10.1099/acmi.0.000595.v3 | 2023 | ||
| In Vivo Targeting of Escherichia coli with Vancomycin-Arginine. | Neville LF, Shalit I, Warn PA, Scheetz MH, Sun J, Chosy MB, Wender PA, Cegelski L, Rendell JT. | Antimicrob Agents Chemother | 10.1128/aac.02416-20 | 2021 | ||
| Carriage of colistin-resistant Gram-negative bacteria in children from communities in Cape Town (Tuberculosis child multidrug-resistant preventive therapy trial sub-study). | Snyman Y, Whitelaw AC, Maloba MRB, Hesseling AC, Newton-Foot M. | S Afr J Infect Dis | 10.4102/sajid.v36i1.241 | 2021 | ||
| Enzymology | A Novel Antimicrobial Peptide, Dermaseptin-SS1, with Anti-Proliferative Activity, Isolated from the Skin Secretion of Phyllomedusa tarsius. | Ma X, Chen Y, Shu A, Jiang Y, Chen X, Ma C, Zhou M, Wang T, Chen T, Shaw C, Wang L. | Molecules | 10.3390/molecules28186558 | 2023 | |
| Challenges, Issues and Warnings from CLSI and EUCAST Working Group on Polymyxin Susceptibility Testing. | Bakthavatchalam YD, Veeraraghavan B. | J Clin Diagn Res | 10.7860/jcdr/2017/27182.10375 | 2017 | ||
| Heteroresistance to colistin in wild-type Klebsiella pneumoniae isolates from clinical origin. | Sanchez-Leon I, Perez-Nadales E, Marin-Sanz JA, Garcia-Martinez T, Martinez-Martinez L. | Microbiol Spectr | 10.1128/spectrum.02238-23 | 2023 | ||
| Enzymology | The accuracy of four commercial broth microdilution tests in the determination of the minimum inhibitory concentration of colistin. | Yusuf E, van Westreenen M, Goessens W, Croughs P. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-020-00383-x | 2020 | |
| In Vitro Potency and Spectrum of the Novel Polymyxin MRX-8 Tested against Clinical Isolates of Gram-Negative Bacteria. | Duncan LR, Wang W, Sader HS. | Antimicrob Agents Chemother | 10.1128/aac.00139-22 | 2022 | ||
| Enzymology | Pharmacokinetics of Colistin in the Gastrointestinal Tract of Poultry Following Dosing via Drinking Water and Its Bactericidal Impact on Enteric Escherichia coli. | Mead A, Richez P, Azzariti S, Pelligand L. | Front Vet Sci | 10.3389/fvets.2021.698135 | 2021 | |
| Enzymology | Occurrence of Beta-Lactamases in Colistin-Resistant Enterobacterales Strains in Poland - a Pilot Study. | Stefaniuk EM, Kozinska A, Wasko I, Baraniak A, Tyski S. | Pol J Microbiol | 10.33073/pjm-2021-021 | 2021 | |
| Pathogenicity | Combining VITEK® 2 with colistin agar dilution screening assist timely reporting of colistin susceptibility. | Lellouche J, Schwartz D, Elmalech N, Ben Dalak MA, Temkin E, Paul M, Geffen Y, Yahav D, Eliakim-Raz N, Durante-Mangoni E, Iossa D, Bernardo M, Daikos GL, Skiada A, Pantazatou A, Antoniadou A, Mouton JW, Carmeli Y, AIDA study group. | Clin Microbiol Infect | 10.1016/j.cmi.2018.09.014 | 2019 | |
| Pathogenicity | Clinical Validation of SensiTest Colistin, a Broth Microdilution-Based Method To Evaluate Colistin MICs. | Carretto E, Brovarone F, Russello G, Nardini P, El-Bouseary MM, Aboklaish AF, Walsh TR, Tyrrell JM. | J Clin Microbiol | 10.1128/jcm.01523-17 | 2018 | |
| Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli. | Abichabki N, Zacharias LV, Moreira NC, Bellissimo-Rodrigues F, Moreira FL, Benzi JRL, Ogasawara TMC, Ferreira JC, Ribeiro CM, Pavan FR, Pereira LRL, Brancini GTP, Braga GUL, Zuardi AW, Hallak JEC, Crippa JAS, Lanchote VL, Canton R, Darini ALC, Andrade LN. | Sci Rep | 10.1038/s41598-022-10393-8 | 2022 | ||
| Rapid high-resolution detection of colistin resistance in Gram-negative bacteria using flow cytometry: a comparison with broth microdilution, a commercial screening test and WGS. | Ekelund O, Klokkhammer Hetland MA, Hoyland Lohr I, Schon T, Somajo S. | J Antimicrob Chemother | 10.1093/jac/dkab328 | 2021 | ||
| Distribution and Antibiotic Resistance Characteristics of Bacteria Isolated from Blood Culture in a Teaching Hospital in Vietnam During 2014-2021. | Van An N, Hoang LH, Le HHL, Thai Son N, Hong LT, Viet TT, Le TD, Thang TB, Vu LH, Nguyen VTH, Xuan Nguyen K. | Infect Drug Resist | 10.2147/idr.s402278 | 2023 | ||
| Genetics | Assessment of Colistin Heteroresistance among Multidrug-Resistant Klebsiella pneumoniae Isolated from Intensive Care Patients in Europe. | Braspenning AJMM, Rajakani SG, Sey A, El Bounja M, Lammens C, Glupczynski Y, Malhotra-Kumar S. | Antibiotics (Basel) | 10.3390/antibiotics13030281 | 2024 | |
| Multi-Drug Resistant Bacteria as Aetiological Factors of Infections in a Tertiary Multidisciplinary Hospital in Poland. | Poletajew S, Pawlik K, Bonder-Nowicka A, Pakuszewski A, Nyk L, Kryst P. | Antibiotics (Basel) | 10.3390/antibiotics10101232 | 2021 | ||
| In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece. | Galani I, Souli M, Katsala D, Karaiskos I, Giamarellou H, Antoniadou A. | J Antimicrob Chemother | 10.1093/jac/dkae077 | 2024 | ||
| Pathogenicity | High prevalence of mcr-1-encoded colistin resistance in commensal Escherichia coli from broiler chicken in Bangladesh. | Ahmed S, Das T, Islam MZ, Herrero-Fresno A, Biswas PK, Olsen JE. | Sci Rep | 10.1038/s41598-020-75608-2 | 2020 | |
| The PitA protein contributes to colistin susceptibility in Pseudomonas aeruginosa. | Erdmann MB, Gardner PP, Lamont IL. | PLoS One | 10.1371/journal.pone.0292818 | 2023 | ||
| Mutations in genes lpxL1, bamA, and pmrB impair the susceptibility of cystic fibrosis strains of Pseudomonas aeruginosa to murepavadin. | Ghassani A, Triponney P, Bour M, Plesiat P, Jeannot K, MucoMicrobes study Group. | Antimicrob Agents Chemother | 10.1128/aac.01298-23 | 2024 | ||
| Epidemiology and zoonotic transmission of mcr-positive and carbapenemase-producing Enterobacterales on German turkey farms. | Nordhoff K, Scharlach M, Effelsberg N, Knorr C, Rocker D, Claussen K, Egelkamp R, Mellmann AC, Moss A, Muller I, Roth SA, Werckenthin C, Wohlke A, Ehlers J, Kock R. | Front Microbiol | 10.3389/fmicb.2023.1183984 | 2023 | ||
| In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020-2021: a multicenter study. | Galani I, Papoutsaki V, Karaiskos I, Moustakas N, Galani L, Maraki S, Mavromanolaki VE, Legga O, Fountoulis K, Platsouka ED, Giannopoulou P, Papadogeorgaki H, Damala M, Chinou E, Pasxali A, Deliolanis I, Vagiakou H, Petinaki E, Chli A, Vagdatli E, Kazila P, Papaioannou V, Kontopoulou K, Ferke AN, Moraitou E, Antoniadou A, Giamarellou H. | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-023-04616-7 | 2023 | ||
| Genetics | Comparative genomics and molecular epidemiology of colistin-resistant Acinetobacter baumannii. | Kabic J, Novovic K, Kekic D, Trudic A, Opavski N, Dimkic I, Jovcic B, Gajic I. | Comput Struct Biotechnol J | 10.1016/j.csbj.2022.12.045 | 2023 | |
| Influence of local epidemiology on the performance of common colistin drug susceptibility testing methods. | Asar L, Pfefferle S, Lutgehetmann M, Hoffmann A, Katchanov J, Aepfelbacher M, Rohde H, Maurer FP. | PLoS One | 10.1371/journal.pone.0217468 | 2019 | ||
| Evaluation of Rapid Polymyxin Pseudomonas test in clinical Pseudomonas aeruginosa isolates with various degrees of multidrug resistance. | Sanchez-Lopez J, Cortes-Cuevas JL, Diez-Aguilar M, Lopez-Causape C, Canton R, Morosini MI. | JAC Antimicrob Resist | 10.1093/jacamr/dlab104 | 2021 | ||
| Prevalence of ESbetaL, AmpC and Colistin-Resistant E. coli in Meat: A Comparison between Pork and Wild Boar. | Rega M, Carmosino I, Bonilauri P, Frascolla V, Vismarra A, Bacci C. | Microorganisms | 10.3390/microorganisms9020214 | 2021 | ||
| Heteroresistance to Colistin in Clinical Isolates of Klebsiella pneumoniae Producing OXA-48. | Sanchez-Leon I, Garcia-Martinez T, Diene SM, Perez-Nadales E, Martinez-Martinez L, Rolain JM. | Antibiotics (Basel) | 10.3390/antibiotics12071111 | 2023 | ||
| Predominance of Acinetobacter spp., Harboring the blaIMP Gene, Contaminating the Hospital Environment in a Tertiary Hospital in Mwanza, Tanzania: A Cross-Sectional Laboratory-Based Study. | Silago V, Mruma EC, Msemwa B, Mtemisika CI, Phillip S, Ndagula RA, Said MM, Mushi MF, Mshana SE. | Pathogens | 10.3390/pathogens11010063 | 2022 | ||
| Occurrence of NDM-1 and VIM-2 Co-Producing Escherichia coli and OprD Alteration in Pseudomonas aeruginosa Isolated from Hospital Environment Samples in Northwestern Tunisia. | Maaroufi R, Dziri O, Hadjadj L, Diene SM, Rolain JM, Chouchani C. | Diagnostics (Basel) | 10.3390/diagnostics11091617 | 2021 | ||
| Acinetobacter Non-baumannii Species: Occurrence in Infections in Hospitalized Patients, Identification, and Antibiotic Resistance. | Sheck E, Romanov A, Shapovalova V, Shaidullina E, Martinovich A, Ivanchik N, Mikotina A, Skleenova E, Oloviannikov V, Azizov I, Vityazeva V, Lavrinenko A, Kozlov R, Edelstein M. | Antibiotics (Basel) | 10.3390/antibiotics12081301 | 2023 | ||
| Phylogeny | Genomic Characterization of Multidrug-Resistant Extended Spectrum beta-Lactamase-Producing Klebsiella pneumoniae from Clinical Samples of a Tertiary Hospital in South Kivu Province, Eastern Democratic Republic of Congo. | Irenge LM, Ambroise J, Bearzatto B, Durant JF, Bonjean M, Gala JL. | Microorganisms | 10.3390/microorganisms11020525 | 2023 | |
| Enzymology | Quantitative Pharmacodynamic Characterization of Resistance versus Heteroresistance of Colistin in E. coli Using a Semimechanistic Modeling of Killing Curves. | Mead A, Toutain PL, Richez P, Pelligand L. | Antimicrob Agents Chemother | 10.1128/aac.00793-22 | 2022 | |
| Colistin Resistance of Non-pathogenic Strains of Escherichia Coli Occurring as Natural Intestinal Flora in Broiler Chickens Treated and not Treated with Colistin Sulphate. | Majewski M, Lukomska A, Wilczynski J, Wystalska D, Racewicz P, Nowacka-Woszuk J, Pszczola M, Anusz K. | J Vet Res | 10.2478/jvetres-2020-0060 | 2020 | ||
| Phenotypic and genotypic characteristics of Pseudomonas aeruginosa isolated from cystic fibrosis patients with chronic infections. | Iwanska A, Trafny EA, Czopowicz M, Augustynowicz-Kopec E. | Sci Rep | 10.1038/s41598-023-39005-9 | 2023 | ||
| Genomic Characteristics of Colistin-Resistant Salmonella enterica subsp. enterica Serovar Infantis from Poultry Farms in the Republic of Serbia. | Jovcic B, Novovic K, Filipic B, Velhner M, Todorovic D, Matovic K, Rasic Z, Nikolic S, Kiskarolj F, Kojic M. | Antibiotics (Basel) | 10.3390/antibiotics9120886 | 2020 | ||
| Enzymology | Detection of mcr-4 positive Salmonella enterica serovar Typhimurium in clinical isolates of human origin, Italy, October to November 2016. | Carretto E, Brovarone F, Nardini P, Russello G, Barbarini D, Pongolini S, Gagliotti C, Carattoli A, Sarti M. | Euro Surveill | 10.2807/1560-7917.es.2018.23.2.17-00821 | 2018 | |
| Evaluation of FASTinov Ultrarapid Flow Cytometry Antimicrobial Susceptibility Testing Directly from Positive Blood Cultures. | Silva-Dias A, Perez-Viso B, Martins-Oliveira I, Gomes R, Rodrigues AG, Canton R, Pina-Vaz C. | J Clin Microbiol | 10.1128/jcm.00544-21 | 2021 | ||
| Evaluation of Vitek®2 performance for colistin susceptibility testing for Gram-negative isolates. | Khurana S, Malhotra R, Mathur P. | JAC Antimicrob Resist | 10.1093/jacamr/dlaa101 | 2020 | ||
| Pathogenicity | An Improved Medium for Colistin Susceptibility Testing. | Gwozdzinski K, Azarderakhsh S, Imirzalioglu C, Falgenhauer L, Chakraborty T. | J Clin Microbiol | 10.1128/jcm.01950-17 | 2018 | |
| Antibiotic resistance of non-fermenting Gram-negative bacilli isolated at a large Infectious Diseases Hospital in North-Eastern Romania, during an 11-year period. | Buzila ER, Nastase EV, Lunca C, Badescu A, Miftode E, Iancu LS. | Germs | 10.18683/germs.2021.1272 | 2021 | ||
| The Intestinal Carriage of Plasmid-Mediated Colistin-Resistant Enterobacteriaceae in Tertiary Care Settings. | Tkadlec J, Kalova A, Brajerova M, Gelbicova T, Karpiskova R, Smelikova E, Nyc O, Drevinek P, Krutova M. | Antibiotics (Basel) | 10.3390/antibiotics10030258 | 2021 | ||
| Molecular Detection of Carbapenemase-Encoding Genes in Multidrug-Resistant Acinetobacter baumannii Clinical Isolates in South Africa. | Anane YA, Apalata T, Vasaikar S, Okuthe GE, Songca S. | Int J Microbiol | 10.1155/2020/7380740 | 2020 | ||
| Re-sensitization of Multidrug-Resistant and Colistin-Resistant Gram-Negative Bacteria to Colistin by Povarov/Doebner-Derived Compounds. | Onyedibe KI, Nemeth AM, Dayal N, Smith RD, Lamptey J, Ernst RK, Melander RJ, Melander C, Sintim HO. | ACS Infect Dis | 10.1021/acsinfecdis.2c00417 | 2023 | ||
| Antibiotic and Metal Resistance in Escherichia coli Isolated from Pig Slaughterhouses in the United Kingdom. | Yang H, Wei SH, Hobman JL, Dodd CER. | Antibiotics (Basel) | 10.3390/antibiotics9110746 | 2020 | ||
| Epidemiological Prevalence of Phenotypical Resistances and Mobilised Colistin Resistance in Avian Commensal and Pathogenic E. coli from Denmark, France, The Netherlands, and the UK. | Mead A, Billon-Lotz C, Olsen R, Swift B, Richez P, Stabler R, Pelligand L. | Antibiotics (Basel) | 10.3390/antibiotics11050631 | 2022 | ||
| Acinetobacter baumannii complex, national laboratory-based surveillance in South Africa, 2017 to 2019. | Perovic O, Duse A, Chibabhai V, Black M, Said M, Prentice E, Wadula J, Mahabeer Y, Han KSS, Mogokotleng R, Strasheim W, Lowe M, Jallow S, Ismail H, for GERMS-SA. | PLoS One | 10.1371/journal.pone.0271355 | 2022 | ||
| Pathogenicity | Application of CRISPR/Cas9-Based Genome Editing in Studying the Mechanism of Pandrug Resistance in Klebsiella pneumoniae. | Sun Q, Wang Y, Dong N, Shen L, Zhou H, Hu Y, Gu D, Chen S, Zhang R, Ji Q. | Antimicrob Agents Chemother | 10.1128/aac.00113-19 | 2019 | |
| Evaluation of Agar Dilution Method in Susceptibility Testing of Polymyxins for Enterobacteriaceae and Non-Fermentative Rods: Advantages Compared to Broth Microdilution and Broth Macrodilution. | Hu X, Sun L, Nie T, Yang Y, Wang X, Pang J, Lu X, Li X, Lu Y, Li C, Yang X, Meng Y, Li G, You X. | Antibiotics (Basel) | 10.3390/antibiotics11101392 | 2022 | ||
| Phenotypic and Genotypic Antimicrobial Resistance in Non-O157 Shiga Toxin-Producing Escherichia coli Isolated From Cattle and Swine in Chile. | Galarce N, Sanchez F, Fuenzalida V, Ramos R, Escobar B, Lapierre L, Paredes-Osses E, Arriagada G, Alegria-Moran R, Lincopan N, Fuentes-Castillo D, Vera-Leiva A, Gonzalez-Rocha G, Bello-Toledo H, Borie C. | Front Vet Sci | 10.3389/fvets.2020.00367 | 2020 | ||
| A prospective matched case-control study on the genomic epidemiology of colistin-resistant Enterobacterales from Dutch patients. | Vendrik KEW, de Haan A, Witteveen S, Hendrickx APA, Landman F, Notermans DW, Bijkerk P, Schoffelen AF, de Greeff SC, Wielders CCH, Goeman JJ, Kuijper EJ, Schouls LM, ColRE survey consortium. | Commun Med (Lond) | 10.1038/s43856-022-00115-6 | 2022 | ||
| Pathogenicity | Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections. | Copp JN, Pletzer D, Brown AS, Van der Heijden J, Miton CM, Edgar RJ, Rich MH, Little RF, Williams EM, Hancock REW, Tokuriki N, Ackerley DF. | mBio | 10.1128/mbio.02068-20 | 2020 | |
| Genetics | Whole-Genome Sequencing of Gram-Negative Bacteria Isolated From Bovine Mastitis and Raw Milk: The First Emergence of Colistin mcr-10 and Fosfomycin fosA5 Resistance Genes in Klebsiella pneumoniae in Middle East. | Tartor YH, Abd El-Aziz NK, Gharieb RMA, El Damaty HM, Enany S, Soliman EA, Abdellatif SS, Attia ASA, Bahnass MM, El-Shazly YA, Elbediwi M, Ramadan H. | Front Microbiol | 10.3389/fmicb.2021.770813 | 2021 | |
| Pathogenicity | Predominance of international clone 2 multidrug-resistant Acinetobacter baumannii clinical isolates in Thailand: a nationwide study. | Khuntayaporn P, Kanathum P, Houngsaitong J, Montakantikul P, Thirapanmethee K, Chomnawang MT. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-021-00424-z | 2021 | |
| Emergence of colistin-resistant hypervirulent Klebsiella pneumoniae (CoR-HvKp) in China. | Liu X, Wu Y, Zhu Y, Jia P, Li X, Jia X, Yu W, Cui Y, Yang R, Xia W, Xu Y, Yang Q. | Emerg Microbes Infect | 10.1080/22221751.2022.2036078 | 2022 | ||
| Pathogenicity | Multicenter Evaluation of Colistin Broth Disk Elution and Colistin Agar Test: a Report from the Clinical and Laboratory Standards Institute. | Humphries RM, Green DA, Schuetz AN, Bergman Y, Lewis S, Yee R, Stump S, Lopez M, Macesic N, Uhlemann AC, Kohner P, Cole N, Simner PJ. | J Clin Microbiol | 10.1128/jcm.01269-19 | 2019 | |
| Genetics | Species Identification and Antibiotic Resistance Prediction by Analysis of Whole-Genome Sequence Data by Use of ARESdb: an Analysis of Isolates from the Unyvero Lower Respiratory Tract Infection Trial. | Ferreira I, Beisken S, Lueftinger L, Weinmaier T, Klein M, Bacher J, Patel R, von Haeseler A, Posch AE. | J Clin Microbiol | 10.1128/jcm.00273-20 | 2020 | |
| Genetics | Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients. | Mohammadi M, Saffari M, Siadat SD, Hejazi SH, Shayestehpour M, Motallebi M, Eidi M. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-023-00567-1 | 2023 | |
| Phenotypic and Genotypic Characterization of Virulence Factors and Susceptibility to Antibiotics in Salmonella Infantis Strains Isolated from Chicken Meat: First Findings in Chile. | Lapierre L, Cornejo J, Zavala S, Galarce N, Sanchez F, Benavides MB, Guzman M, Saenz L. | Animals (Basel) | 10.3390/ani10061049 | 2020 | ||
| Genetics | Characterization of Carbapenemase-Producing Klebsiella pneumoniae Isolates from Two Romanian Hospitals Co-Presenting Resistance and Heteroresistance to Colistin. | Foldes A, Oprea M, Szekely E, Usein CR, Dobreanu M. | Antibiotics (Basel) | 10.3390/antibiotics11091171 | 2022 | |
| Antibiotic Resistance in the Alternative Lifestyles of Campylobacter jejuni. | Rossi DA, Dumont CF, Santos ACS, Vaz MEL, Prado RR, Monteiro GP, Melo CBDS, Stamoulis VJ, Dos Santos JP, de Melo RT. | Front Cell Infect Microbiol | 10.3389/fcimb.2021.535757 | 2021 | ||
| Pathogenicity | Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations. | Ezadi F, Ardebili A, Mirnejad R. | J Clin Microbiol | 10.1128/jcm.01390-18 | 2019 | |
| Antibacterial Cotton Fabric Functionalized with Copper Oxide Nanoparticles. | Roman LE, Gomez ED, Solis JL, Gomez MM. | Molecules | 10.3390/molecules25245802 | 2020 | ||
| Goldilocks Dilemma: LPS Works Both as the Initial Target and a Barrier for the Antimicrobial Action of Cationic AMPs on E. coli. | Jakubec M, Rylandsholm FG, Rainsford P, Silk M, Bril'kov M, Kristoffersen T, Juskewitz E, Ericson JU, Svendsen JSM. | Biomolecules | 10.3390/biom13071155 | 2023 | ||
| High prevalence of blaCTX-M-15 type extended-spectrum beta-lactamases in Gambian hooded vultures (Necrosyrtes monachus): A threatened species with substantial human interaction. | Woksepp H, Camara F, Bonnedahl J. | Microbiologyopen | 10.1002/mbo3.1349 | 2023 |
| #20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 ) |
| #24520 | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 105182 |
| #63750 | Culture Collection University of Gothenburg (CCUG) ; Curators of the CCUG; CCUG 70662 |
| #66792 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) . |
| #68368 | Automatically annotated from API 20E . |
| #68374 | Automatically annotated from API ID32E . |
| #125438 | Julia Koblitz, Lorenz Christian Reimer, Rüdiger Pukall, Jörg Overmann: Predicting bacterial phenotypic traits through improved machine learning using high-quality, curated datasets. 2024 ( DOI 10.1101/2024.08.12.607695 ) |
| #125439 | Philipp Münch, René Mreches, Martin Binder, Hüseyin Anil Gündüz, Xiao-Yin To, Alice McHardy: deepG: Deep Learning for Genome Sequence Data. R package version 0.3.1 . |
| #126262 | A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 ) |
You found an error in BacDive? Please tell us about it!
Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.
Successfully sent
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive132730.20260601.11
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data